CopyMark Law Group
4.9/5
Drawing for QUANTOOM

USPTO serial 79353355

QUANTOOM

Reviewed by CopyMark Law Group

Reg. 7483809Status 700Registered
Filing date
Status date
Registration date
Aug 27, 2024
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QUANTOOM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D Hyra

Clifford D Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
007Industrial machines for the production of nucleic acids; parts of industrial machines for the production of nucleic acids, namely, single use trays of reactor tubesACTIVE—
040Custom manufacturing of biologics, namely, custom manufacturing of biologics using biological organisms in the manufacturing process; custom manufacturing of nucleic acids for clinical trials and for commercial supply by pharmaceutical compounders; custom manufacturing services in the field of biologics, pharmaceuticals, biopharmaceuticals, health care, cell culture and gene therapy and medical products, namely, custom manufacturing of biologic, pharmaceuticals, and biopharmaceuticals; treatment of pharmaceutical and chemical products and their components during the custom manufacture of pharmaceuticals, biopharmaceuticals and nucleic acids; providing advice related to the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply; providing information in the field of the custom manufacture of nucleic acids for clinical trials and for commercial supplyACTIVE—
042Scientific research and technological consultancy services in the field of analysis and production of nucleic acids; research and development of nucleic acid generation platforms; scientific research and development applied in particular in the biological, technological and biotechnological fields, namely, design of processes, equipment, disposables and consumables for producing nucleic acids; scientific research and technological development and advice services, namely, custom design, sequencing in the nature of testing, analysis and evaluation and development of nucleic acid generation platforms; engineering services; scientific research and technological consultancy on process development relating to manufacture of nucleic acids; industrial process development for manufacturing of medical preparations; engineering services and scientific research and technological consultancy, all on production units for DNA and RNA synthesis; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; technological development services in the nature of product development, technology advice and information services in the nature of providing technology information in the field of pharmaceuticals and engineering consultation services in the field of the production of nucleic acidsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 1, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 13, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 13, 2025FIMPFINAL DISPOSITION PROCESSED—
Nov 27, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 27, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 27, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 23, 2024TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jun 2, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 8, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 20, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 20, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 19, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jan 3, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 3, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 21, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 1, 2023RFNTREFUSAL PROCESSED BY IB—
Jul 10, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 10, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 3, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 3, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 2, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2023DOCKASSIGNED TO EXAMINER—
Oct 25, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance